To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma
Clinical trial NCT05363202 · UNKNOWN
Trial details
- NCT number
- NCT05363202
- Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2024-05-30
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.